Percutaneous Coronary Artery Stenting of Unprotected Left Main Coronary Artery Disease Using Drug-Eluting Stents: The Initial Baylor University Medical Center Experience

Significant narrowing of the left main coronary artery is a high-risk condition with significant mortality risk. Bypass surgery is the current gold-standard treatment for unprotected left main (ULM) disease. Stenting utilizing drug-eluting stents (DES) is another therapeutic option for patients with...

Full description

Saved in:
Bibliographic Details
Published in:Proceedings - Baylor University. Medical Center 2007-10, Vol.20 (4), p.339-343
Main Authors: Garner, William Lance, Stoler, Robert C., Laible, Emily A., Kang, Mi Jung, Choi, James W.
Format: Article
Language:English
Subjects:
Care and treatment
Coronary heart disease
Health aspects
Patient outcomes
Stent (Surgery)
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Significant narrowing of the left main coronary artery is a high-risk condition with significant mortality risk. Bypass surgery is the current gold-standard treatment for unprotected left main (ULM) disease. Stenting utilizing drug-eluting stents (DES) is another therapeutic option for patients with ULM disease considered too high risk for bypass surgery or for patients who simply refuse bypass surgery. We have had great initial success with ULM stenting using DES in 10 selected patients at Baylor University Medical Center. Ongoing multicenter, international randomized studies comparing percutaneous coronary intervention with DES and bypass surgery will shed more light on the best treatment strategy for ULM coronary disease.
ISSN:0899-8280
1525-3252
DOI:10.1080/08998280.2007.11928317